HYALURONIDASE

HYALURONIDASE was reported 4830 times

HYALURONIDASE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VISUAL ACUITY TESTS NORMAL 1 0.5000
1 GRIP STRENGTH 105 0.4585
2 HYALURONIC ACID DECREASED 1 0.3333
3 DERMAL FILLER OVERCORRECTION 1 0.3333
4 SWOLLEN JOINT COUNT 61 0.2440
5 PURTSCHER RETINOPATHY 16 0.1951
6 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 15 0.1429
7 DEEP VEIN THROMBOSIS POSTOPERATIVE 236 0.1178
8 PAROPHTHALMIA 27 0.1134
9 SCLERAL DEGENERATION 1 0.1111
10 TENDER JOINT COUNT 9 0.1071
11 LUPUS VULGARIS 134 0.1063
12 SWOLLEN JOINT COUNT ABNORMAL 2 0.1053
13 C-REACTIVE PROTEIN 87 0.0939
14 PORPHYRIA ACUTE 132 0.0920
15 ACUTE MACULAR NEURORETINOPATHY 15 0.0877
16 X-RAY ABNORMAL 152 0.0849
17 ACQUIRED PORPHYRIA 6 0.0845
18 RETINITIS 137 0.0792
19 VACCINATION SITE DISCOLOURATION 1 0.0769
20 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 156 0.0752
21 ELECTROCARDIOGRAM T WAVE AMPLITUDE INCREASED 7 0.0745
22 ASIA SYNDROME 1 0.0667
23 TRIGEMINAL PALSY 3 0.0652
24 SWOLLEN JOINT COUNT INCREASED 201 0.0630
25 DISLOCATION OF VERTEBRA 143 0.0626
26 PIK3CA RELATED OVERGROWTH SPECTRUM 1 0.0625
27 OCULOCARDIAC REFLEX 1 0.0625
28 FACET JOINT SYNDROME 202 0.0620
29 CONJUNCTIVAL BLEB 3 0.0556
30 LAGOPHTHALMOS 20 0.0489
31 RHEUMATIC FEVER 217 0.0486
32 PERIPHERAL VENOUS DISEASE 196 0.0479
33 ANTIPHOSPHOLIPID ANTIBODIES 9 0.0462
34 SUPERIOR SEMICIRCULAR CANAL DEHISCENCE 1 0.0435
35 CORNEAL GRAFT FAILURE 1 0.0435
36 OPEN GLOBE INJURY 7 0.0424
37 BONE EROSION 138 0.0390
38 RETINAL WHITE DOTS SYNDROME 1 0.0385
39 C-REACTIVE PROTEIN ABNORMAL 238 0.0371
40 CAVERNOUS SINUS SYNDROME 1 0.0370
41 DUODENAL ULCER PERFORATION 259 0.0348
42 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 226 0.0348
43 RHEUMATOID FACTOR POSITIVE 200 0.0346
44 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 238 0.0332
45 DRUG TOLERANCE DECREASED 91 0.0324
46 HYPOCHOLESTEROLAEMIA 11 0.0312
47 INTRAOCULAR PRESSURE FLUCTUATION 6 0.0305
48 NODAL MARGINAL ZONE B-CELL LYMPHOMA 1 0.0294
49 SOFT TISSUE ATROPHY 2 0.0282
50 SKIN LAXITY 12 0.0274
51 MUSCLE INJURY 226 0.0272
52 AUTOIMMUNE DISORDER 259 0.0265
53 XANTHELASMA 3 0.0261
54 HELICOBACTER INFECTION 265 0.0258
55 THECAL SAC COMPRESSION 1 0.0256
56 CONJUNCTIVAL OEDEMA 25 0.0243
57 PRODUCT SELECTION ISSUE 1 0.0238
58 BREAST CANCER STAGE III 153 0.0236
59 FOLLICULITIS 244 0.0232
60 LIP DRY 210 0.0231
61 DISORDER OF ORBIT 3 0.0208
62 MATERNAL EXPOSURE TIMING UNSPECIFIED 75 0.0199
63 BURSITIS 241 0.0198
64 ORBITAL OEDEMA 10 0.0198
65 HAND DEFORMITY 246 0.0187
66 ORBITAL COMPARTMENT SYNDROME 1 0.0182
67 PEMPHIGUS 222 0.0177
68 CELLULITIS ORBITAL 10 0.0172
69 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 11 0.0165
70 GRIP STRENGTH DECREASED 143 0.0162
71 MYOPATHY TOXIC 10 0.0162
72 ADMINISTRATION SITE SCAR 1 0.0161
73 JOINT RANGE OF MOTION DECREASED 206 0.0153
74 LUPUS-LIKE SYNDROME 136 0.0150
75 FACIAL WASTING 4 0.0149
76 WOUND INFECTION 162 0.0148
77 MISOPHONIA 1 0.0147
78 PERIORBITAL DISORDER 3 0.0146
79 OCULAR RETROBULBAR HAEMORRHAGE 2 0.0144
80 LYMPHANGIECTASIA 1 0.0143
81 EXOSTOSIS 128 0.0140
82 MUSCLE FIBROSIS 1 0.0137
83 SCIATICA 218 0.0137
84 MENINGITIS CHEMICAL 3 0.0136
85 HYPERCHOLESTEROLAEMIA 131 0.0136
86 LID SULCUS DEEPENED 5 0.0134
87 PERICARDITIS 218 0.0130
88 STIFF TONGUE 1 0.0123
89 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 13 0.0122
90 EYE OPERATION COMPLICATION 2 0.0122
91 OBESITY 194 0.0122
92 SYNOVITIS 214 0.0119
93 WALKING AID USER 78 0.0118
94 OCULAR ISCHAEMIC SYNDROME 1 0.0118
95 LOWER LIMB FRACTURE 225 0.0117
96 EXOPHTHALMOS 25 0.0116
97 FOOT DEFORMITY 125 0.0113
98 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 6 0.0107
99 GLOSSODYNIA 236 0.0105
100 SERONEGATIVE ARTHRITIS 12 0.0105
101 MULTIPLE DRUG HYPERSENSITIVITY 1 0.0104
102 JOINT DESTRUCTION 16 0.0103
103 FIBROMYALGIA 239 0.0098
104 ADENOCARCINOMA METASTATIC 2 0.0097
105 IRRITABLE BOWEL SYNDROME 206 0.0096
106 LIVER INJURY 202 0.0082
107 CONGENITAL ANOMALY 63 0.0081
108 PULMONARY FIBROSIS 153 0.0080
109 WOUND 221 0.0079
110 RED BLOOD CELL SEDIMENTATION RATE INCREASED 87 0.0079
111 HEPATIC CIRRHOSIS 143 0.0076
112 HIP ARTHROPLASTY 114 0.0074
113 TYPE 2 DIABETES MELLITUS 250 0.0074
114 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 7 0.0074
115 JOINT DISLOCATION 78 0.0074
116 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 125 0.0074
117 LYMPHANGIOMA 1 0.0072
118 VASCULAR STENT STENOSIS 3 0.0071
119 IMPAIRED HEALING 229 0.0070
120 DERMATOCHALASIS 1 0.0068
121 SYSTEMIC LUPUS ERYTHEMATOSUS 241 0.0068
122 CAUDA EQUINA SYNDROME 5 0.0065
123 LIVE BIRTH 54 0.0064
124 RETINAL ARTERY OCCLUSION 16 0.0063
125 EXTRAOCULAR MUSCLE DISORDER 2 0.0062
126 PRESCRIBED OVERDOSE 119 0.0061
127 NIGHT SWEATS 198 0.0061
128 CARDIOACTIVE DRUG LEVEL ABOVE THERAPEUTIC 1 0.0060
129 ANAESTHETIC COMPLICATION 16 0.0060
130 PNEUMONIA PARAINFLUENZAE VIRAL 1 0.0059
131 PELVIC FLOOR MUSCLE WEAKNESS 1 0.0058
132 CARDIOACTIVE DRUG LEVEL DECREASED 1 0.0058
133 VACCINATION SITE SWELLING 1 0.0058
134 BLOOD OESTROGEN ABNORMAL 1 0.0058
135 PREGNANCY 116 0.0058
136 HYPHAEMA 3 0.0057
137 BLOOD CHOLESTEROL INCREASED 268 0.0057
138 WEIGHT FLUCTUATION 60 0.0057
139 EYELASH CHANGES 1 0.0056
140 PROCEDURAL FAILURE 1 0.0056
141 KNEE ARTHROPLASTY 118 0.0056
142 ROAD TRAFFIC ACCIDENT 234 0.0056
143 TOXIC ANTERIOR SEGMENT SYNDROME 6 0.0055
144 ANAESTHESIA 2 0.0055
145 OSTEOARTHRITIS 230 0.0054
146 LOWER RESPIRATORY TRACT INFECTION 245 0.0054
147 ASPARTATE AMINOTRANSFERASE ABNORMAL 8 0.0052
148 PSORIATIC ARTHROPATHY 213 0.0052
149 OCULAR PROCEDURAL COMPLICATION 1 0.0052
150 BLOOD PHOSPHORUS INCREASED 14 0.0051
151 EAR INFECTION 131 0.0049
152 LIVER DISORDER 218 0.0049
153 OPTIC ATROPHY 8 0.0049
154 SYSTEMIC TOXICITY 1 0.0049
155 FREQUENT BOWEL MOVEMENTS 131 0.0048
156 DELIRIUM 163 0.0047
157 ARTHROPATHY 258 0.0046
158 VACCINATION SITE ERYTHEMA 1 0.0046
159 BLISTER 250 0.0044
160 ANAESTHETIC COMPLICATION NEUROLOGICAL 4 0.0044
161 DISCOMFORT 267 0.0044
162 LUNG DISORDER 214 0.0044
163 INFUSION SITE REACTION 13 0.0043
164 MUSCLE SWELLING 4 0.0043
165 BREAKTHROUGH COVID-19 1 0.0043
166 PERIORBITAL INFLAMMATION 1 0.0043
167 RESPIRATORY DISORDER 129 0.0043
168 STOMATITIS 258 0.0042
169 RETINAL DYSTROPHY 1 0.0042
170 INTRAOCULAR PRESSURE TEST 1 0.0042
171 INFECTIVE SPONDYLITIS 1 0.0041
172 BREAST CANCER STAGE II 34 0.0041
173 STRABISMUS 12 0.0041
174 FOREIGN BODY REACTION 1 0.0041
175 ILLNESS ANXIETY DISORDER 1 0.0041
176 MUSCULOSKELETAL PAIN 213 0.0041
177 HEPATIC ENZYME INCREASED 275 0.0040
178 SOFT TISSUE INJURY 3 0.0040
179 EYE INJURY 12 0.0039
180 AUTOPHOBIA 1 0.0039
181 CATARACT OPERATION COMPLICATION 2 0.0039
182 CORNEAL THINNING 1 0.0039
183 RECTAL HAEMORRHAGE 167 0.0039
184 RED BLOOD CELL SEDIMENTATION RATE DECREASED 1 0.0038
185 OPHTHALMOPLEGIA 6 0.0038
186 GAIT INABILITY 127 0.0038
187 INFLAMMATION 195 0.0038
188 OPTIC NERVE DISORDER 6 0.0037
189 PROTEIN TOTAL DECREASED 14 0.0037
190 WHITE BLOOD CELL COUNT INCREASED 142 0.0037
191 BLEPHAROSPASM 23 0.0036
192 PERIORBITAL HAEMATOMA 3 0.0036
193 ONYCHOMADESIS 15 0.0036
194 COLITIS ULCERATIVE 159 0.0036
195 EXCESSIVE SKIN 1 0.0035
196 ULCER HAEMORRHAGE 24 0.0035
197 INFUSION RELATED REACTION 233 0.0035
198 OEDEMA 188 0.0035
199 PREMATURE AGEING 1 0.0034
200 ILL-DEFINED DISORDER 206 0.0034
201 CATHETER SITE HAEMATOMA 1 0.0034
202 LABORATORY TEST ABNORMAL 99 0.0034
203 FROSTBITE 1 0.0033
204 CONTRAINDICATED PRODUCT ADMINISTERED 101 0.0033
205 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 57 0.0033
206 EAR INFECTION FUNGAL 1 0.0033
207 WHEEZING 196 0.0033
208 MOBILITY DECREASED 233 0.0032
209 JOINT STIFFNESS 85 0.0032
210 DEVICE PROGRAMMING ERROR 1 0.0032
211 FACIAL ASYMMETRY 3 0.0031
212 COLD-STIMULUS HEADACHE 1 0.0031
213 SKIN TEXTURE ABNORMAL 3 0.0031
214 FOREIGN BODY IN EYE 3 0.0031
215 IATROGENIC INJURY 4 0.0031
216 C-REACTIVE PROTEIN INCREASED 112 0.0031
217 CELLULITE 1 0.0031
218 PSEUDOSTROKE 1 0.0029
219 DEATH NEONATAL 4 0.0029
220 OSTEOPOROSIS 118 0.0029
221 OVERLAP SYNDROME 2 0.0029
222 INJURY 201 0.0029
223 DRY MOUTH 231 0.0028
224 CONTUSION 271 0.0028
225 HYPERNATRAEMIA 14 0.0028
226 INDURATION 5 0.0028
227 ABSCESS BACTERIAL 1 0.0028
228 SYPHILIS 2 0.0028
229 ATROPHIC VULVOVAGINITIS 2 0.0027
230 LIVIDITY 1 0.0027
231 MATERNAL EXPOSURE DURING PREGNANCY 241 0.0027
232 SWELLING 251 0.0027
233 POLYARTHRITIS 14 0.0027
234 PANCREATITIS 139 0.0026
235 LIPID METABOLISM DISORDER 1 0.0026
236 PRESCRIBED UNDERDOSE 52 0.0026
237 GASTROINTESTINAL DISORDER 232 0.0026
238 CONVULSIVE THRESHOLD LOWERED 1 0.0025
239 LIPOEDEMA 1 0.0025
240 MUSCULOSKELETAL STIFFNESS 223 0.0025
241 CATHETER SITE EXTRAVASATION 1 0.0025
242 SINUSITIS 254 0.0025
243 IIIRD NERVE PARALYSIS 2 0.0025
244 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 8 0.0024
245 AMNESIA 156 0.0024
246 ASTHMA 270 0.0024
247 AMAUROSIS 2 0.0024
248 EXPOSURE VIA EYE CONTACT 1 0.0024
249 DRUG TOLERANCE 12 0.0024
250 PSEUDOMONAL BACTERAEMIA 2 0.0023
251 TISSUE INJURY 1 0.0023
252 INTERCEPTED DRUG ADMINISTRATION ERROR 1 0.0023
253 EXTRADURAL HAEMATOMA 3 0.0023
254 GENERAL ANAESTHESIA 1 0.0022
255 SKIN WRINKLING 6 0.0022
256 IMMUNOGLOBULINS DECREASED 3 0.0022
257 EXTRAOCULAR MUSCLE PARESIS 1 0.0022
258 VITREOUS HAEMORRHAGE 6 0.0022
259 EATING DISORDER SYMPTOM 1 0.0022
260 FEELING HOT 131 0.0021
261 SKIN INDENTATION 1 0.0021
262 SENSORY LOSS 17 0.0021
263 BLOOD ELECTROLYTES DECREASED 3 0.0021
264 BLOOD CHOLESTEROL 1 0.0021
265 LIPOATROPHY 2 0.0021
266 NAIL INFECTION 3 0.0021
267 VITREOUS DISORDER 1 0.0021
268 RHEUMATOID ARTHRITIS 235 0.0021
269 NAIL DISORDER 18 0.0021
270 GENERAL PHYSICAL HEALTH DETERIORATION 234 0.0020
271 EAR PAIN 39 0.0020
272 URINARY TRACT PAIN 1 0.0020
273 THERAPY NON-RESPONDER 89 0.0020
274 SPINAL FUSION SURGERY 8 0.0020
275 THERAPEUTIC PRODUCT EFFECT DECREASED 87 0.0019
276 SPONDYLITIS 7 0.0019
277 ARTHRITIS 151 0.0019
278 ABDOMINAL INJURY 1 0.0019
279 IRIDOCYCLITIS 6 0.0019
280 VASCULAR OCCLUSION 4 0.0019
281 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
282 PROTEIN TOTAL INCREASED 5 0.0019
283 PERIORBITAL CELLULITIS 1 0.0019
284 BLOOD IMMUNOGLOBULIN A INCREASED 1 0.0019
285 JOINT SWELLING 220 0.0018
286 GINGIVAL SWELLING 8 0.0018
287 QUADRIPARESIS 3 0.0018
288 SOFT TISSUE DISORDER 2 0.0018
289 ABDOMINAL DISCOMFORT 298 0.0018
290 APNOEIC ATTACK 1 0.0018
291 PUSTULAR PSORIASIS 6 0.0017
292 COLLAGEN DISORDER 1 0.0017
293 HYPOAESTHESIA 252 0.0017
294 LYMPHATIC DISORDER 1 0.0017
295 BACK INJURY 18 0.0017
296 PUPILLARY DISORDER 1 0.0016
297 SLEEP DISORDER 114 0.0016
298 CONFUSIONAL STATE 260 0.0016
299 CONJUNCTIVAL HAEMORRHAGE 6 0.0016
300 SKIN ATROPHY 9 0.0016
301 GINGIVAL RECESSION 3 0.0016
302 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 1 0.0016
303 HYPOALBUMINAEMIA 12 0.0015
304 VASCULAR DEVICE INFECTION 7 0.0015
305 INFECTION 223 0.0015
306 MUSCULAR WEAKNESS 174 0.0015
307 BROW PTOSIS 1 0.0015
308 HYPERSENSITIVITY 278 0.0015
309 ALOPECIA 294 0.0015
310 EYE MOVEMENT DISORDER 10 0.0015
311 SURGICAL PROCEDURE REPEATED 1 0.0015
312 DRUG INTOLERANCE 140 0.0014
313 FUNCTIONAL GASTROINTESTINAL DISORDER 5 0.0014
314 MIGRAINE 137 0.0014
315 INTRAOCULAR PRESSURE TEST ABNORMAL 1 0.0014
316 FACIAL DISCOMFORT 1 0.0014
317 EYE ROLLING 1 0.0014
318 CONNECTIVE TISSUE DISORDER 2 0.0014
319 SYSTEMIC SCLERODERMA 1 0.0014
320 SYMPTOM MASKED 1 0.0014
321 DYSPEPSIA 135 0.0014
322 LIP EROSION 1 0.0014
323 BLOOD PHOSPHORUS DECREASED 5 0.0014
324 NEUTROPHIL COUNT INCREASED 14 0.0014
325 RETINAL VASCULAR OCCLUSION 1 0.0014
326 PERIPHERAL SWELLING 208 0.0013
327 CORNEAL DEPOSITS 1 0.0013
328 SERRATIA INFECTION 1 0.0013
329 URTICARIA 225 0.0013
330 BRAIN STEM SYNDROME 1 0.0013
331 INTRAOCULAR PRESSURE INCREASED 17 0.0013
332 PAPILLOEDEMA 6 0.0013
333 ADRENAL INSUFFICIENCY 16 0.0013
334 HYPERTENSION 279 0.0013
335 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
336 CHEST PAIN 243 0.0013
337 TREATMENT FAILURE 108 0.0013
338 RECTAL CANCER 4 0.0013
339 LYMPHOEDEMA 9 0.0013
340 EYELID DISORDER 3 0.0013
341 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 62 0.0013
342 NORMAL NEWBORN 7 0.0013
343 CORNEAL TRANSPLANT 1 0.0013
344 PARAESTHESIA 201 0.0013
345 IMMUNODEFICIENCY 19 0.0013
346 CROUP INFECTIOUS 1 0.0013
347 TINEA PEDIS 2 0.0013
348 PERFORATION 1 0.0012
349 NASOPHARYNGITIS 228 0.0012
350 STRESS CARDIOMYOPATHY 7 0.0012
351 ABDOMINAL PAIN UPPER 245 0.0012
352 PERIORBITAL PAIN 1 0.0012
353 OEDEMA PERIPHERAL 142 0.0012
354 INTENTIONAL PRODUCT USE ISSUE 101 0.0012
355 HYPERTRANSAMINASAEMIA 8 0.0011
356 MUSCLE SPASMS 211 0.0011
357 MEMORY IMPAIRMENT 157 0.0011
358 ONYCHOMYCOSIS 5 0.0011
359 DECREASED APPETITE 260 0.0011
360 ORAL FUNGAL INFECTION 3 0.0011
361 TYPE IV HYPERSENSITIVITY REACTION 3 0.0011
362 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0011
363 PSYCHOMOTOR RETARDATION 3 0.0011
364 WEIGHT INCREASED 237 0.0011
365 MYELOPATHY 2 0.0011
366 VISUAL IMPAIRMENT 129 0.0010
367 TELANGIECTASIA 1 0.0010
368 TASTE DISORDER 21 0.0010
369 EYELID OEDEMA 12 0.0010
370 FINGER DEFORMITY 5 0.0010
371 PRODUCT LABEL CONFUSION 6 0.0010
372 JOINT NOISE 2 0.0010
373 MEDICATION ERROR 56 0.0010
374 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
375 SKIN OEDEMA 1 0.0010
376 SENSORY DISTURBANCE 16 0.0010
377 HYPOPHYSITIS 2 0.0010
378 LYMPHOPENIA 14 0.0010
379 REDUCED FACIAL EXPRESSION 1 0.0010
380 AKINESIA 2 0.0010
381 EJECTION FRACTION DECREASED 15 0.0010
382 PERIORBITAL OEDEMA 5 0.0010
383 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
384 SINUSITIS BACTERIAL 1 0.0009
385 EXPOSURE DURING PREGNANCY 59 0.0009
386 INNER EAR DISORDER 1 0.0009
387 SUBRETINAL FLUID 1 0.0009
388 ADVERSE EVENT 84 0.0009
389 DISABILITY 18 0.0009
390 SKIN INJURY 3 0.0009
391 CORNEAL OEDEMA 2 0.0009
392 MYOCARDIAL INJURY 1 0.0009
393 EYELID PTOSIS 9 0.0009
394 ANXIETY 252 0.0009
395 HALO VISION 1 0.0009
396 LIVER FUNCTION TEST INCREASED 19 0.0009
397 MOANING 1 0.0009
398 PUPILS UNEQUAL 1 0.0009
399 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 16 0.0009
400 RETINAL DETACHMENT 8 0.0009
401 OPTIC NERVE INJURY 1 0.0009
402 DEFORMITY 8 0.0009
403 RETINAL HAEMORRHAGE 6 0.0008
404 BLOOD UREA INCREASED 14 0.0008
405 RASH VESICULAR 4 0.0008
406 CONDITION AGGRAVATED 251 0.0008
407 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
408 COELIAC DISEASE 8 0.0008
409 POST-ACUTE COVID-19 SYNDROME 1 0.0008
410 ALLERGY TO CHEMICALS 1 0.0008
411 INFUSION SITE SWELLING 5 0.0008
412 POST PROCEDURAL COMPLICATION 15 0.0008
413 MYOSITIS 7 0.0008
414 RETINAL DEGENERATION 1 0.0008
415 EPIGASTRIC DISCOMFORT 3 0.0008
416 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
417 LIP INJURY 1 0.0008
418 VISUAL ACUITY REDUCED 25 0.0008
419 INSOMNIA 200 0.0008
420 PLASMA CELL MYELOMA REFRACTORY 1 0.0007
421 ASTHENIA 281 0.0007
422 DEPRESSION 170 0.0007
423 MUSCLE TWITCHING 17 0.0007
424 SKIN DEPIGMENTATION 1 0.0007
425 ISCHAEMIC HEPATITIS 1 0.0007
426 ASPIRATION 8 0.0007
427 ADVERSE DRUG REACTION 65 0.0007
428 EPILEPSY 22 0.0007
429 PYREXIA 246 0.0007
430 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
431 MYDRIASIS 9 0.0007
432 VASCULAR INJURY 1 0.0007
433 GAIT DISTURBANCE 132 0.0007
434 ADENOVIRUS INFECTION 2 0.0007
435 PRODUCT USE ISSUE 128 0.0007
436 KNEE DEFORMITY 1 0.0007
437 ARTHRALGIA 280 0.0007
438 SKIN STRIAE 1 0.0007
439 HYPOKALAEMIA 31 0.0007
440 BLOOD BILIRUBIN INCREASED 18 0.0007
441 ASTIGMATISM 1 0.0007
442 MOUTH INJURY 1 0.0007
443 WEIGHT DECREASED 184 0.0007
444 IRITIS 2 0.0007
445 KERATITIS 2 0.0007
446 ASCITES 19 0.0006
447 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
448 APNOEA 5 0.0006
449 TRANSCRIPTION MEDICATION ERROR 1 0.0006
450 DRUG-INDUCED LIVER INJURY 20 0.0006
451 MUSCLE ATROPHY 8 0.0006
452 PHARYNGEAL PARAESTHESIA 1 0.0006
453 NECK PAIN 35 0.0006
454 PRURITUS 235 0.0006
455 INFUSION SITE HAEMORRHAGE 2 0.0006
456 INJECTION RELATED REACTION 1 0.0006
457 UPPER RESPIRATORY TRACT INFECTION 28 0.0006
458 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
459 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
460 OSTEOPENIA 9 0.0006
461 FACIAL PARALYSIS 5 0.0006
462 PUPIL FIXED 1 0.0006
463 SPINAL CORD INJURY 1 0.0006
464 MUSCLE SPASTICITY 7 0.0006
465 DRUG ADMINISTERED AT INAPPROPRIATE SITE 6 0.0006
466 MACULOPATHY 2 0.0006
467 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
468 MALAISE 242 0.0006
469 UNDERDOSE 40 0.0005
470 PUPILLARY REFLEX IMPAIRED 1 0.0005
471 GRANULOCYTE COUNT DECREASED 1 0.0005
472 VOMITING 253 0.0005
473 LYMPH NODE PAIN 1 0.0005
474 GENERAL SYMPTOM 4 0.0005
475 PERIORBITAL SWELLING 3 0.0005
476 LIP DISORDER 1 0.0005
477 PANCREATIC CYST 1 0.0005
478 DIZZINESS 261 0.0005
479 DEVICE RELATED INFECTION 8 0.0005
480 ATROPHY 1 0.0005
481 RASH 224 0.0005
482 CEREBRAL HAEMORRHAGE 18 0.0005
483 ABDOMINAL PAIN 116 0.0005
484 SMALL INTESTINAL HAEMORRHAGE 1 0.0005
485 FUNGAL SKIN INFECTION 2 0.0005
486 EYELID PAIN 1 0.0005
487 BACK DISORDER 8 0.0005
488 IMMUNE-MEDIATED HEPATITIS 1 0.0005
489 EXTRAVASATION 2 0.0005
490 VENOUS THROMBOSIS LIMB 1 0.0005
491 PNEUMONIA 153 0.0005
492 DYSPNOEA 267 0.0005
493 CRYING 17 0.0005
494 INFUSION SITE BRUISING 1 0.0005
495 INJECTION SITE INDENTATION 1 0.0005
496 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
497 INFECTIOUS MONONUCLEOSIS 1 0.0004
498 HEADACHE 279 0.0004
499 RASH PRURITIC 24 0.0004
500 SUSPECTED OFF LABEL USE 2 0.0004
501 DIARRHOEA 282 0.0004
502 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1 0.0004
503 ROSACEA 2 0.0004
504 SKIN TIGHTNESS 2 0.0004
505 INGROWING NAIL 1 0.0004
506 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 30 0.0004
507 URINE FLOW DECREASED 1 0.0004
508 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
509 VISUAL FIELD DEFECT 3 0.0004
510 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
511 EYE OEDEMA 1 0.0004
512 BODY TEMPERATURE DECREASED 4 0.0004
513 RETINAL TEAR 1 0.0004
514 DEVICE INFUSION ISSUE 1 0.0004
515 TACHYCARDIA 35 0.0004
516 FATIGUE 305 0.0004
517 PAIN IN EXTREMITY 115 0.0004
518 PHYSICAL DECONDITIONING 1 0.0004
519 DIPLOPIA 10 0.0004
520 POSTMENOPAUSAL HAEMORRHAGE 1 0.0004
521 BRAIN FOG 6 0.0004
522 AGITATION 28 0.0004
523 DEPRESSED MOOD 20 0.0004
524 GASTROOESOPHAGEAL REFLUX DISEASE 30 0.0004
525 PRODUCT USE IN UNAPPROVED INDICATION 91 0.0004
526 PAIN 224 0.0004
527 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
528 EOSINOPHILIC OESOPHAGITIS 1 0.0004
529 NERVE INJURY 4 0.0004
530 HAEMORRHOIDS 7 0.0004
531 SKIN HYPERTROPHY 1 0.0004
532 INFUSION SITE ERYTHEMA 3 0.0004
533 REBOUND EFFECT 4 0.0004
534 EYE SWELLING 13 0.0003
535 EXERCISE TOLERANCE DECREASED 2 0.0003
536 LUNG CANCER METASTATIC 1 0.0003
537 MUSCLE STRAIN 3 0.0003
538 PARAPLEGIA 1 0.0003
539 BODY TEMPERATURE INCREASED 7 0.0003
540 FACIAL PAIN 3 0.0003
541 ENDOPHTHALMITIS 2 0.0003
542 METABOLIC ENCEPHALOPATHY 1 0.0003
543 BONE MARROW DISORDER 1 0.0003
544 INJECTION SITE VESICLES 2 0.0003
545 PRESYNCOPE 8 0.0003
546 MENISCUS INJURY 2 0.0003
547 MULTIPLE-DRUG RESISTANCE 1 0.0003
548 INFUSION SITE EXTRAVASATION 2 0.0003
549 THERAPY PARTIAL RESPONDER 5 0.0003
550 ASPARTATE AMINOTRANSFERASE INCREASED 17 0.0003
551 EYE INFLAMMATION 3 0.0003
552 WHITE BLOOD CELL COUNT ABNORMAL 2 0.0003
553 CUSHINGOID 1 0.0003
554 HYPOVENTILATION 1 0.0003
555 MUCOSAL INFLAMMATION 8 0.0003
556 SKIN MASS 2 0.0003
557 BRAIN INJURY 3 0.0003
558 SCAR 5 0.0003
559 APLASIA PURE RED CELL 1 0.0003
560 VIITH NERVE PARALYSIS 1 0.0003
561 GRANULOMA 1 0.0003
562 MASS 4 0.0003
563 BRONCHIOLITIS 1 0.0003
564 TYPE I HYPERSENSITIVITY 1 0.0003
565 OSTEONECROSIS OF JAW 7 0.0003
566 IRRITABILITY 17 0.0003
567 FACIAL PARESIS 1 0.0003
568 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
569 HYPERACUSIS 1 0.0003
570 RETINOPATHY 1 0.0003
571 PARANASAL SINUS DISCOMFORT 1 0.0003
572 PRODUCT STORAGE ISSUE 1 0.0003
573 THERAPEUTIC RESPONSE DECREASED 16 0.0003
574 FACE INJURY 1 0.0003
575 OFF LABEL USE 230 0.0003
576 PROCEDURAL COMPLICATION 2 0.0003
577 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
578 FOETAL EXPOSURE DURING PREGNANCY 21 0.0003
579 WOUND SECRETION 1 0.0003
580 TRIGEMINAL NEURALGIA 1 0.0002
581 ORGAN FAILURE 1 0.0002
582 EYE PAIN 14 0.0002
583 MUSCLE DISORDER 2 0.0002
584 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
585 ACCIDENTAL OVERDOSE 9 0.0002
586 BLOOD CREATININE INCREASED 16 0.0002
587 RESPIRATORY DEPRESSION 3 0.0002
588 PHOTOSENSITIVITY REACTION 4 0.0002
589 SUICIDAL BEHAVIOUR 1 0.0002
590 LEUKOPENIA 12 0.0002
591 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
592 NAUSEA 186 0.0002
593 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
594 UTERINE HAEMORRHAGE 1 0.0002
595 INFUSION SITE PAIN 3 0.0002
596 NEOPLASM PROGRESSION 8 0.0002
597 BLOOD CALCIUM INCREASED 2 0.0002
598 GROIN PAIN 2 0.0002
599 LOSS OF CONSCIOUSNESS 29 0.0002
600 ADVERSE REACTION 3 0.0002
601 HEAD DISCOMFORT 4 0.0002
602 BLINDNESS 9 0.0002
603 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
604 BALANCE DISORDER 19 0.0002
605 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
606 HAEMOGLOBIN INCREASED 1 0.0002
607 EAR DISORDER 1 0.0002
608 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
609 LOCALISED OEDEMA 1 0.0002
610 SKIN REACTION 3 0.0002
611 SKIN ABRASION 1 0.0002
612 SKIN DISORDER 7 0.0002
613 ENDOMETRIOSIS 1 0.0002
614 IMPAIRED QUALITY OF LIFE 3 0.0002
615 LIMB OPERATION 1 0.0002
616 HUMERUS FRACTURE 1 0.0002
617 THROMBOCYTOPENIA 23 0.0002
618 INFLAMMATORY BOWEL DISEASE 2 0.0002
619 ABDOMINAL TENDERNESS 1 0.0002
620 TREATMENT NONCOMPLIANCE 11 0.0002
621 DRY EYE 10 0.0002
622 VEIN DISORDER 1 0.0002
623 BURNING SENSATION 14 0.0002
624 PSORIASIS 26 0.0002
625 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
626 KLEBSIELLA INFECTION 1 0.0002
627 AMMONIA INCREASED 1 0.0002
628 HEPATITIS 5 0.0002
629 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
630 VARICOSE VEIN 1 0.0002
631 SKIN NECROSIS 1 0.0002
632 BRONCHITIS 14 0.0002
633 GINGIVITIS 1 0.0002
634 ERYTHEMA OF EYELID 1 0.0002
635 HOSPITALISATION 28 0.0002
636 ASTHENOPIA 1 0.0002
637 INTESTINAL ISCHAEMIA 1 0.0002
638 INJECTION SITE INJURY 1 0.0002
639 ANGIOPATHY 1 0.0002
640 MACULAR OEDEMA 1 0.0002
641 OCULAR DISCOMFORT 2 0.0002
642 OXYGEN SATURATION DECREASED 10 0.0002
643 PERONEAL NERVE PALSY 1 0.0002
644 VISUAL DISTURBANCE 1 0.0002
645 SKIN DISCOLOURATION 8 0.0002
646 HYPOVOLAEMIA 1 0.0002
647 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
648 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
649 CATARACT OPERATION 1 0.0002
650 MYOCLONUS 2 0.0002
651 INJECTION SITE EXTRAVASATION 2 0.0002
652 PIGMENTATION DISORDER 1 0.0002
653 PHARYNGITIS 2 0.0002
654 NASAL DRYNESS 1 0.0002
655 PHOTOPHOBIA 3 0.0002
656 BLOOD SODIUM DECREASED 3 0.0002
657 MULTIPLE INJURIES 1 0.0002
658 SWELLING FACE 10 0.0002
659 NODULE 2 0.0002
660 SEDATION 4 0.0002
661 PRODUCT PREPARATION ISSUE 1 0.0002
662 IMMUNE SYSTEM DISORDER 2 0.0002
663 SARS-COV-2 TEST POSITIVE 2 0.0002
664 COLITIS ISCHAEMIC 1 0.0001
665 PLEURAL EFFUSION 9 0.0001
666 PALLOR 4 0.0001
667 DRUG TOXICITY 2 0.0001
668 BACK PAIN 34 0.0001
669 CROHN'S DISEASE 1 0.0001
670 ECCHYMOSIS 1 0.0001
671 ENCEPHALITIS 1 0.0001
672 LARGE INTESTINE PERFORATION 1 0.0001
673 ORAL DISCOMFORT 2 0.0001
674 APHONIA 2 0.0001
675 DUODENAL ULCER 1 0.0001
676 SEASONAL ALLERGY 2 0.0001
677 DIVERTICULUM 1 0.0001
678 FEAR OF INJECTION 1 0.0001
679 BRONCHOSPASM 2 0.0001
680 CARDIOGENIC SHOCK 2 0.0001
681 RASH PUSTULAR 1 0.0001
682 HAEMOGLOBIN DECREASED 14 0.0001
683 MEDICAL DEVICE COMPLICATION 1 0.0001
684 CEREBRAL DISORDER 1 0.0001
685 HYPOAESTHESIA ORAL 2 0.0001
686 TROPONIN INCREASED 1 0.0001
687 ACIDOSIS 1 0.0001
688 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
689 MUSCULOSKELETAL CHEST PAIN 2 0.0001
690 TENDONITIS 2 0.0001
691 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
692 CONSTIPATION 28 0.0001
693 DRUG INEFFECTIVE 169 0.0001
694 HAEMORRHAGIC STROKE 1 0.0001
695 MULTIPLE ALLERGIES 1 0.0001
696 PRODUCT QUALITY ISSUE 17 0.0001
697 NEURALGIA 3 0.0001
698 ESCHERICHIA INFECTION 1 0.0001
699 HEMIPLEGIA 1 0.0001
700 HOT FLUSH 9 0.0001
701 CELLULITIS 6 0.0001
702 CANDIDA INFECTION 2 0.0001
703 SKIN HYPERPIGMENTATION 1 0.0001
704 INJECTION SITE REACTION 8 0.0001
705 NEUROPATHY PERIPHERAL 11 0.0001
706 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
707 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
708 TREMOR 19 0.0001
709 ANGIOEDEMA 5 0.0001
710 WRONG DRUG ADMINISTERED 1 0.0001
711 OPTIC NEURITIS 1 0.0001
712 PNEUMONIA BACTERIAL 1 0.0001
713 NERVE COMPRESSION 1 0.0001
714 GRAND MAL CONVULSION 1 0.0001
715 BREAST CANCER STAGE I 1 0.0001
716 ERYTHEMA MULTIFORME 1 0.0001
717 EPISTAXIS 8 0.0001
718 PAIN IN JAW 3 0.0001
719 ACUTE RESPIRATORY FAILURE 2 0.0001
720 SINUS DISORDER 2 0.0001
721 BLADDER DISORDER 1 0.0001
722 HYPOTONIA 1 0.0001
723 URINARY TRACT INFECTION 17 0.0001
724 ANAEMIA 19 0.0001
725 VAGINAL DISCHARGE 1 0.0001
726 SEPSIS 11 0.0001
727 FLUID RETENTION 5 0.0001
728 SLUGGISHNESS 1 0.0001
729 EAR DISCOMFORT 1 0.0001
730 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
731 INFLUENZA LIKE ILLNESS 8 0.0001
732 POOR VENOUS ACCESS 1 0.0001
733 EYE DISCHARGE 1 0.0001
734 TENDERNESS 1 0.0001
735 HAEMORRHAGE 10 0.0001
736 INJECTION SITE DISCOMFORT 1 0.0001
737 INCONTINENCE 1 0.0001
738 SKIN LACERATION 1 0.0001
739 SEPTIC SHOCK 4 0.0001
740 PRODUCT DISPENSING ERROR 2 0.0001
741 STAPHYLOCOCCAL INFECTION 3 0.0001
742 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
743 SKIN INFECTION 1 0.0001
744 MYOCARDIAL ISCHAEMIA 1 0.0001
745 ERYTHEMA 18 0.0001
746 NEOPLASM 1 0.0001
747 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1 0.0001
748 ABDOMINAL DISTENSION 9 0.0001
749 ARRHYTHMIA 4 0.0001
750 ATAXIA 1 0.0001
751 CHOLECYSTITIS 1 0.0001
752 SKIN BURNING SENSATION 6 0.0001
753 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
754 INJECTION SITE PAIN 25 0.0001
755 GENERALISED OEDEMA 1 0.0001
756 CYST 1 0.0001
757 INJECTION SITE DISCOLOURATION 1 0.0001
758 INTENTIONAL PRODUCT MISUSE 7 0.0001
759 DYSARTHRIA 3 0.0001
760 POISONING 1 0.0001
761 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
762 UNRESPONSIVE TO STIMULI 2 0.0001
763 HAEMATOMA 2 0.0001
764 RESPIRATORY TRACT INFECTION 2 0.0001
765 ORAL CANDIDIASIS 1 0.0001
766 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
767 QUALITY OF LIFE DECREASED 1 0.0001
768 BLOOD GLUCOSE INCREASED 14 0.0001
769 SINUS CONGESTION 1 0.0001
770 DEVICE BREAKAGE 3 0.0001
771 NEUTROPENIA 10 0.0001
772 SKIN LESION 2 0.0001
773 ANAPHYLACTIC REACTION 4 0.0001
774 HAEMOPTYSIS 2 0.0001
775 BLOOD TEST ABNORMAL 1 0.0001
776 SINUS TACHYCARDIA 1 0.0001
777 CONVULSION 4 0.0001
778 ANOSMIA 1 0.0001
779 DEVICE DISLOCATION 3 0.0001
780 SKIN HAEMORRHAGE 1 0.0001
781 DRY SKIN 9 0.0001
782 VISION BLURRED 9 0.0001
783 DRUG DISPENSING ERROR 1 0.0001
784 INSURANCE ISSUE 1 0.0001
785 TINNITUS 3 0.0001
786 DEVICE ADHESION ISSUE 1 0.0001
787 THYROID DISORDER 1 0.0001
788 LIMB DISCOMFORT 2 0.0001
789 NERVOUS SYSTEM DISORDER 2 0.0001
790 OCULAR HYPERAEMIA 3 0.0001
791 INJECTION SITE BRUISING 5 0.0001
792 MUSCLE TIGHTNESS 1 0.0001
793 DRUG LEVEL INCREASED 1 0.0001
794 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
795 EXPIRED PRODUCT ADMINISTERED 2 0.0001
796 VIRAL INFECTION 2 0.0001
797 LIP SWELLING 2 0.0001
798 CIRCULATORY COLLAPSE 1 0.0001
799 NEUROTOXICITY 1 0.0001
800 AMENORRHOEA 1 0.0001
801 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
802 THIRST 1 0.0001
803 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
804 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
805 GASTROENTERITIS VIRAL 1 0.0001
806 BONE DISORDER 1 0.0001
807 PANIC ATTACK 2 0.0001
808 CONJUNCTIVITIS 1 0.0001
809 BACTERIAL INFECTION 1 0.0001
810 DEATH 46 0.0001
811 GASTRIC ULCER 1 0.0001
812 MUSCULOSKELETAL DISORDER 1 0.0001
813 FEELING JITTERY 1 0.0001
814 INJECTION SITE SWELLING 4 0.0001
815 GLAUCOMA 1 0.0001
816 HERNIA 1 0.0001
817 ORAL HERPES 1 0.0001
818 CHILLS 6 0.0001
819 HAEMATOCRIT DECREASED 1 0.0001
820 UPPER LIMB FRACTURE 1 0.0001
821 CYTOKINE RELEASE SYNDROME 1 0.0000
822 PRODUCT ADMINISTRATION ERROR 1 0.0000
823 DYSKINESIA 2 0.0000
824 INJURY ASSOCIATED WITH DEVICE 1 0.0000
825 NEUTROPHIL COUNT DECREASED 2 0.0000
826 PRODUCT PREPARATION ERROR 1 0.0000
827 CARDIAC ARREST 4 0.0000
828 PULMONARY HYPERTENSION 1 0.0000
829 DERMATITIS 1 0.0000
830 SKIN EXFOLIATION 4 0.0000
831 PLATELET COUNT DECREASED 5 0.0000
832 IMPAIRED WORK ABILITY 1 0.0000
833 POOR QUALITY SLEEP 1 0.0000
834 DEEP VEIN THROMBOSIS 3 0.0000
835 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
836 MELAENA 1 0.0000
837 TOOTH DISORDER 1 0.0000
838 DISEASE PROGRESSION 5 0.0000
839 COMA 2 0.0000
840 PRODUCT PRESCRIBING ERROR 1 0.0000
841 OVERDOSE 9 0.0000
842 BLOOD PRESSURE FLUCTUATION 1 0.0000
843 LOCALISED INFECTION 1 0.0000
844 HYPOGLYCAEMIA 2 0.0000
845 RESPIRATORY FAILURE 3 0.0000
846 ENCEPHALOPATHY 1 0.0000
847 AGEUSIA 1 0.0000
848 ABDOMINAL PAIN LOWER 1 0.0000
849 PRODUCT COMPLAINT 1 0.0000
850 CARDIOVASCULAR DISORDER 1 0.0000
851 DRUG RESISTANCE 1 0.0000
852 SKIN ULCER 1 0.0000
853 RASH GENERALISED 1 0.0000
854 SPEECH DISORDER 2 0.0000
855 DRUG INTERACTION 6 0.0000
856 BRADYCARDIA 2 0.0000
857 MENSTRUATION IRREGULAR 1 0.0000
858 THROAT TIGHTNESS 1 0.0000
859 MOOD ALTERED 1 0.0000
860 RESPIRATORY ARREST 1 0.0000
861 PANCYTOPENIA 2 0.0000
862 DEMENTIA 1 0.0000
863 RENAL IMPAIRMENT 3 0.0000
864 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
865 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
866 DYSPHONIA 2 0.0000
867 BONE PAIN 2 0.0000
868 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
869 ACUTE MYOCARDIAL INFARCTION 1 0.0000
870 URINARY INCONTINENCE 1 0.0000
871 RENAL INJURY 1 0.0000
872 BLOOD POTASSIUM DECREASED 1 0.0000
873 HEPATIC FAILURE 1 0.0000
874 NO ADVERSE EVENT 6 0.0000
875 LACRIMATION INCREASED 1 0.0000
876 CORONARY ARTERY DISEASE 1 0.0000
877 OROPHARYNGEAL PAIN 3 0.0000
878 MOOD SWINGS 1 0.0000
879 MOVEMENT DISORDER 1 0.0000
880 LACTIC ACIDOSIS 1 0.0000
881 EYE DISORDER 1 0.0000
882 BLOOD PRESSURE DECREASED 2 0.0000
883 URINARY RETENTION 1 0.0000
884 NEOPLASM MALIGNANT 2 0.0000
885 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
886 ILLNESS 3 0.0000
887 HEART RATE DECREASED 1 0.0000
888 LYMPHADENOPATHY 1 0.0000
889 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
890 HYPERGLYCAEMIA 1 0.0000
891 INFLUENZA 3 0.0000
892 COLITIS 1 0.0000
893 CHRONIC KIDNEY DISEASE 2 0.0000
894 HYPOTENSION 5 0.0000
895 CARDIAC FAILURE 2 0.0000
896 SOMNOLENCE 5 0.0000
897 EXTRA DOSE ADMINISTERED 1 0.0000
898 LUNG NEOPLASM MALIGNANT 1 0.0000
899 INJECTION SITE ERYTHEMA 3 0.0000
900 RHABDOMYOLYSIS 1 0.0000
901 CARDIO-RESPIRATORY ARREST 1 0.0000
902 RENAL FAILURE ACUTE 1 0.0000
903 HYPOACUSIS 1 0.0000
904 MENTAL DISORDER 1 0.0000
905 COVID-19 4 0.0000
906 PULMONARY OEDEMA 1 0.0000
907 DEVICE ISSUE 2 0.0000
908 RENAL DISORDER 1 0.0000
909 FALL 7 0.0000
910 DISEASE RECURRENCE 1 0.0000
911 RASH ERYTHEMATOUS 1 0.0000
912 FEELING ABNORMAL 5 0.0000
913 INTERSTITIAL LUNG DISEASE 1 0.0000
914 ATRIAL FIBRILLATION 2 0.0000
915 PRODUCT DOSE OMISSION ISSUE 6 0.0000
916 HEART RATE INCREASED 2 0.0000
917 CHEST DISCOMFORT 2 0.0000
918 ECZEMA 1 0.0000
919 DISTURBANCE IN ATTENTION 1 0.0000
920 HAEMATOCHEZIA 1 0.0000
921 HYPONATRAEMIA 1 0.0000
922 INCORRECT DOSE ADMINISTERED 4 0.0000
923 HERPES ZOSTER 1 0.0000
924 LETHARGY 1 0.0000
925 EYE IRRITATION 1 0.0000
926 NASAL CONGESTION 1 0.0000
927 CATARACT 1 0.0000
928 VERTIGO 1 0.0000
929 DEVICE DIFFICULT TO USE 1 0.0000
930 FEBRILE NEUTROPENIA 1 0.0000
931 DEHYDRATION 2 0.0000
932 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
933 COUGH 4 0.0000
934 DEVICE MALFUNCTION 1 0.0000
935 HALLUCINATION 1 0.0000
936 ACUTE KIDNEY INJURY 2 0.0000
937 INJECTION SITE HAEMORRHAGE 1 0.0000
938 CEREBROVASCULAR ACCIDENT 2 0.0000
939 SUICIDAL IDEATION 1 0.0000
940 BREAST CANCER 1 0.0000
941 CARDIAC DISORDER 1 0.0000
942 SYNCOPE 1 0.0000
943 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
944 FLUSHING 1 0.0000
945 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
946 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
947 EMOTIONAL DISTRESS 1 0.0000
948 RENAL FAILURE 1 0.0000
949 BLOOD PRESSURE INCREASED 1 0.0000
950 TOXICITY TO VARIOUS AGENTS 1 0.0000
951 MYALGIA 1 0.0000